NVO - Tesla Investor Ross Gerber Backs Ozempic's Potential To Reduce Monthly Food Expenses — Less Eating More Saving | Benzinga
Ross Gerber, a prominent Tesla investor, has suggested that using Ozempic could lead to significant cost savings.
What Happened: Gerber took to X (formerly Twitter) to share his thoughts on the potential financial benefits of using Ozempic, a weight-loss drug developed by Novo Nordisk A/S (NYSE:NVO).
Gerber said, “It's possible that using ozempic might actually save people money too.”
He quoted a user who claimed that their expenses at restaurants and grocery stores had drastically decreased since starting the medication, potentially saving them close to $1,000 a month.
It's possible that using ozempic might actually save people money too. https://t.co/FJSWnn4mCP — Ross Gerber (@GerberKawasaki) March 20, 2024
Gerber’s comment was in response to a post by a user named Vito, who expressed concern about the potential impact of Ozempic on the food and beverage industry. The user, who is on the medication along with his wife, reported a significant reduction in their monthly spending on food-related items.